AES 2023

December 01-05, 2023
Orlando, FL

American Epilepsy Society 2023

Explore more Neuroscience congress materials

Results(9)

Neuroscience

Caregiver-reported seizure outcomes with real-world use of cannabidiol in tuberous sclerosis complex: interim results from the BECOME-TSC survey

Author(s): Mary K. Koenig MD, The University of Texas Health Science Center at Houston

Neuroscience

Cannabidiol and sodium valproate demonstrate pharmacodynamics synergism in an acute mouse model of generalised seizures

Author(s): Rohini R. Rana PhD, Jazz Pharmaceuticals

Neuroscience

Long-term effectiveness of cannabidiol against focal-onset seizures in treatment-resistant epilepsies

Author(s): Yong D. Park MD, Medical College of Georgia at Augusta University, Department of Neurology

Neuroscience

Caregiver-reported nonseizure outcomes with real-world use of cannabidiol in tuberous sclerosis complex: interim results from the BECOME-TSC Survey

Author(s): Sarah M.L. Wilson MD, University of Arkansas for Medical Sciences

Neuroscience

Efficacy and safety of cannabidiol for seizures associated with tuberous sclerosis complex in pediatric and adult patients from GWPCARE6: a phase 3 trial with an open-label extension

Author(s): Elizabeth Thiele MD, PhD, Massachusetts General Hospital

Neuroscience

Real-world outcomes of cannabidiol in treatment-resistant epilepsies: experience from the Expanded Access Program

Author(s): Anup D. Patel MD, Nationwide Children’s Hospital, Columbus, Ohio, USA

Neuroscience

Long-term effectiveness of cannabidiol against focal seizures in tuberous sclerosis complex: results from the GWPCARE6 open-label extension trial

Author(s): Joyce Y. Wu MD, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine

Neuroscience

Change in antiseizure and anxiolytic medications pre- and post-cannabidiol initiation

Author(s): Gang Fang PharmD, Jazz Pharmaceuticals

Neuroscience

Real-world safety and effectiveness of cannabidiol in adults with treatment-resistant epilepsies: long-term results from the United States Expanded Access Program

Author(s): Jerzy P. Szaflarski MD, PhD, University of Alabama at Birmingham

Neuroscience

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.